Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.240
-0.010 (-0.80%)
At close: Jun 26, 2026, 4:00 PM EDT
1.240
0.00 (0.00%)
Pre-market: Jun 29, 2026, 5:57 AM EDT
Milestone Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Milestone Pharmaceuticals stock have an average target of 7.25, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 484.68% from the current stock price of 1.24.
Analyst Consensus: Buy
* Price targets were last updated on May 26, 2026.
Analyst Ratings
The average analyst rating for Milestone Pharmaceuticals stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $8 | Buy | Maintains | $8 | +545.16% | May 26, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $7 | Buy | Reiterates | $7 | +464.52% | May 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $8 | Buy | Maintains | $8 | +545.16% | May 13, 2026 |
| Raymond James | Raymond James | Buy Initiates $6 | Buy | Initiates | $6 | +383.87% | Apr 9, 2026 |
Financial Forecast
Revenue This Year
7.14M
from 1.55M
Increased by 362.08%
Revenue Next Year
29.53M
from 7.14M
Increased by 313.33%
EPS This Year
-0.97
from -0.75
EPS Next Year
-1.05
from -0.97
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.3M | 40.5M | |
| Avg | 7.1M | 29.5M | |
| Low | 4.0M | 21.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 566.2% | 466.9% | |
| Avg | 362.1% | 313.3% | |
| Low | 158.7% | 194.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.97 | -1.05 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.